Find out what makes us such a unique institution and discover the vibrant student life that is at the heart of our community.
Learn more about our key research areas and our research objectives.
See how our research transforms people’s lives in our community, throughout the UK and around the world
We're putting £5.8 million of Office for Students funding towards improving facilities and equipment for our students.
Dr Síle Molloy in the Institute for Infection and Immunity has been selected as one of 32 ‘emerging leaders’ to become a member of the UK Young Academy.
Dr Angela Loyse BsC MBBS FRCP is a researcher, implementation expert, infectious diseases physician and advocacy lead. Angela's current work spans clinical trials, implementation projects, large scale implementation, advocacy and policy related to HIV-related CNS infection, paediatrics and Advanced HIV disease/AIDS. Angela was the chief investigator of the DREAMM project (www.dreamm.net) and leads the End AIDS Action group (www.endaidsaction.group).
Biography
Dr Angela Loyse trained in infectious diseases and works on clinical trials, implementation science projects, large scale implementation and advocacy initiatives mainly in low- and middle-income countries. She is passionate about locally led, patient-centred health system strengthening. Angela was the chief investigator of the DREAMM implementation science project (www.dreamm.net) that reduced by 50% short term mortality from central nervous system infections in 5 public hospitals in Malawi, Tanzania and Cameroon. In 2023, Angela launched the End AIDS Action Group (www.endaidsaction.group) that expands upon (in terms of geographic and disease areas) the work of the Cryptococcal Meningitis Action Group (CryptoMAG). As chair and lead of cryptoMAG since 2013, she lobbied DNDi to develop a slow-release formulation of the lifesaving medicine flucytosine and is now the deputy director and access lead for the EDCTP-funded DNDi coordinated 5FC HIV Crypto project. From 2019 to December 2022, Angela was the sole technical advisor to Unitaid's Advanced HIV disease programme that was implemented by the Clinton health Access Initiative. She led the technical development of the Global Advanced HIV Diseases toolkit incorporating many DREAMM educational materials and devised the 'hub-and spoke-' model of care for advanced HIV disease.
Measures of esteem
Current roles
Previous roles
Browser does not support script.